Antimicrobial stewardship programs in adult intensive care units in Latin America: Implementation, assessments, and impact on outcomes.


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
02 2022
Historique:
pubmed: 9 4 2021
medline: 15 3 2022
entrez: 8 4 2021
Statut: ppublish

Résumé

To assess the impact of antimicrobial stewardship programs (ASPs) in adult medical-surgical intensive care units (MS-ICUs) in Latin America. Quasi-experimental prospective with continuous time series. The study included 77 MS-ICUs in 9 Latin American countries. Adult patients admitted to an MS-ICU for at least 24 hours were included in the study. This multicenter study was conducted over 12 months. To evaluate the ASPs, representatives from all MS-ICUs performed a self-assessment survey (0-100 scale) at the beginning and end of the study. The impact of each ASP was evaluated monthly using the following measures: antimicrobial consumption, appropriateness of antimicrobial treatments, crude mortality, and multidrug-resistant microorganisms in healthcare-associated infections (MDRO-HAIs). Using final stewardship program quality self-assessment scores, MS-ICUs were stratified and compared among 3 groups: ≤25th percentile, >25th to <75th percentile, and ≥75th percentile. In total, 77 MS-ICU from 9 Latin American countries completed the study. Twenty MS-ICUs reached at least the 75th percentile at the end of the study in comparison with the same number who remain within the 25th percentile (score, 76.1 ± 7.5 vs 28.0 ± 7.3; P < .0001). Several indicators performed better in the MS-ICUs in the 75th versus 25th percentiles: antimicrobial consumption (143.4 vs 159.4 DDD per 100 patient days; P < .0001), adherence to clinical guidelines (92.5% vs 59.3%; P < .0001), validation of prescription by pharmacist (72.0% vs 58.0%; P < .0001), crude mortality (15.9% vs 17.7%; P < .0001), and MDRO-HAIs (9.45 vs 10.96 cases per 1,000 patient days; P = .004). MS-ICUs with more comprehensive ASPs showed significant improvement in antimicrobial utilization.

Identifiants

pubmed: 33829982
pii: S0899823X21000805
doi: 10.1017/ice.2021.80
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

181-190

Auteurs

Rodolfo E Quirós (RE)

Clínica Ángel Foianini, Santa Cruz de la Sierra, Bolivia.

Ana C Bardossy (AC)

Henry Ford Health System, Detroit, Michigan, United States.

Patricia Angeleri (P)

Dirección Nacional de Epidemiología y Análisis de Situación de Salud, MSN, Buenos Aires, Argentina.

Jeannete Zurita (J)

Hospital Vozandes, Quito, Ecuador.

Washington R Aleman Espinoza (WR)

Universidad Espíritu Santo, Hospital Alcívar, Guayaquil, Ecuador.

Marcelo Carneiro (M)

Hospital Santa Cruz-Programa Strictu Sensu em Promoção da Saúde-UNISC, Rio Grande do Sul, Brazil.

Silvia Guerra (S)

Federación de Prestadores Médicos del Interior (FEPREMI), Uruguay.

Julio Medina (J)

Federación de Prestadores Médicos del Interior (FEPREMI), Uruguay.

Ximena Castañeda Luquerna (X)

Fundación Cardio-Infantil, Clínica de la Mujer, Hospital Mederi, Bogotá, Colombia.

Alexander Guerra (A)

Clínica Rey David, Cali, Colombia.

Silvio Vega (S)

Complejo Hospitalario Metropolitano y Sistema Nacional de Investigadores, Panama City, Panama.

Luis E Cuellar Ponce de Leon (LE)

Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú.

José Munita (J)

Facultad de Medicina Clinica Alemana, Universidad del Desarrollo, Millennium Initiative for Collaborative Research On Bacterial Resistance (MICROB-R), Santiago, Chile.

Elvio D Escobar (ED)

Clínica Ángel Foianini, Santa Cruz de la Sierra, Bolivia.

Gina Maki (G)

Henry Ford Health System, Detroit, Michigan, United States.

Tyler Prentiss (T)

Henry Ford Health System, Detroit, Michigan, United States.

Marcus Zervos (M)

Henry Ford Health System, Detroit, Michigan, United States.
Wayne State University School of Medicine, Detroit, Michigan, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH